Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
ReWalk Robotics Ltd (LFWD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: LFWD (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -55.94% | Avg. Invested days 19 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 18.82M USD | Price to earnings Ratio - | 1Y Target Price 9 |
Price to earnings Ratio - | 1Y Target Price 9 | ||
Volume (30-day avg) 3848377 | Beta 1.74 | 52 Weeks Range 1.25 - 6.00 | Updated Date 04/2/2025 |
52 Weeks Range 1.25 - 6.00 | Updated Date 04/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -3.33 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Revenue by Geography
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -112.78% | Operating Margin (TTM) -79.96% |
Management Effectiveness
Return on Assets (TTM) -26.89% | Return on Equity (TTM) -88.56% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 12949597 | Price to Sales(TTM) 0.73 |
Enterprise Value 12949597 | Price to Sales(TTM) 0.73 | ||
Enterprise Value to Revenue 0.5 | Enterprise Value to EBITDA 1.04 | Shares Outstanding 10630300 | Shares Floating 9492735 |
Shares Outstanding 10630300 | Shares Floating 9492735 | ||
Percent Insiders 3.46 | Percent Institutions 10.68 |
Analyst Ratings
Rating 4.5 | Target Price 9.5 | Buy 1 | Strong Buy 1 |
Buy 1 | Strong Buy 1 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
ReWalk Robotics Ltd
Company Overview
History and Background
ReWalk Robotics Ltd. was founded in 2001 by Dr. Amit Goffer after he became quadriplegic. The company develops, manufactures, and markets wearable robotic exoskeletons for individuals with lower limb disabilities. Initially focused on rehabilitation exoskeletons, it has expanded into personal use devices.
Core Business Areas
- Personal Exoskeletons: Designs and manufactures exoskeletons for daily use by individuals with spinal cord injuries to enable them to stand and walk independently.
- Rehabilitation Exoskeletons: Develops exoskeletons used in rehabilitation centers for therapy and training purposes.
Leadership and Structure
The leadership team includes Larry Jasinski (CEO), and the organizational structure is based on functional departments such as R&D, manufacturing, sales, and marketing.
Top Products and Market Share
Key Offerings
- ReWalk Personal: A robotic exoskeleton designed for individuals with spinal cord injury to enable them to stand and walk at home and in the community. Competitors include Ekso Bionics and Parker Hannifin (Indego). Market share data is unavailable but estimated to be between 20-30% of the personal exoskeleton market. The number of users is unavailable but estimated to be in the hundreds globally. Revenue data is unavailable.
- ReWalk Rehabilitation: A robotic exoskeleton designed for use in rehabilitation centers to provide gait training for individuals with spinal cord injury and stroke. Competitors include Ekso Bionics and Hocoma. Market share data is unavailable but estimated to be between 15-25% of the rehabilitation exoskeleton market. The number of users is unavailable but estimated to be in the hundreds globally. Revenue data is unavailable.
Market Dynamics
Industry Overview
The exoskeleton market is growing, driven by advancements in robotics and increasing awareness of the benefits of exoskeletons for rehabilitation and mobility. It is also driven by the increase in the number of spinal cord injuries.
Positioning
ReWalk Robotics Ltd. is a key player in the exoskeleton market, known for its personal and rehabilitation exoskeletons. Its competitive advantages include its established brand and focus on spinal cord injury. The company also sells in the US market.
Total Addressable Market (TAM)
The global exoskeleton market is projected to reach $4.6 billion by 2030. ReWalk is positioned to capture a portion of this market by selling its personal and rehabilitation exoskeletons, but significant competition limits the degree to which ReWalk can gain share.
Upturn SWOT Analysis
Strengths
- Established brand recognition
- Focus on spinal cord injury
- FDA clearance for personal and rehabilitation exoskeletons
- Early mover advantage
Weaknesses
- High product cost
- Limited insurance coverage
- Dependence on reimbursement policies
- Relatively small company size compared to competitors
Opportunities
- Expanding into new applications such as stroke rehabilitation
- Developing more affordable and accessible exoskeletons
- Securing favorable reimbursement policies
- Partnerships with hospitals and rehabilitation centers
Threats
- Increasing competition from larger companies
- Technological advancements that could render existing products obsolete
- Unfavorable changes in reimbursement policies
- Product liability risks
Competitors and Market Share
Key Competitors
- EKSO
- PARKER HANNIFIN (PH)
Competitive Landscape
ReWalk Robotics faces competition from larger, more established companies with greater resources. ReWalk's advantages are its focus on spinal cord injury and established brand. Its disadvantages include smaller size and financial resources.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Growth has been slow and inconsistent due to market access challenges and high product costs.
Future Projections: Future growth depends on the successful commercialization of new products, expansion into new markets, and securing favorable reimbursement policies. Analyst estimates vary.
Recent Initiatives: Recent initiatives include expanding sales efforts, developing new products, and advocating for favorable reimbursement policies.
Summary
ReWalk Robotics is a pioneer in the exoskeleton industry with a focus on spinal cord injury, but its financial stability and market penetration are constrained by high product costs, limited insurance coverage, and competition from larger firms. The company needs to secure reimbursement approvals and aggressively expand sales efforts. Its success hinges on favorable changes in healthcare policies and significant technological advancements. ReWalk has opportunities in stroke rehabilitation and more affordable devices.
Similar Companies
EKSO
Ekso Bionics Holdings Inc
EKSO
Ekso Bionics Holdings Inc
PH
Parker-Hannifin Corporation
PH
Parker-Hannifin Corporation
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Market Research Reports
- Industry News
- Analyst Reports
Disclaimers:
The data provided is for informational purposes only and should not be considered investment advice. Market share data is estimated based on available information. Financial performance is based on publicly available information. Always conduct thorough research before making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About ReWalk Robotics Ltd
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2014-09-12 | CEO & Director Mr. Lawrence J. Jasinski BS, MBA | ||
Sector Healthcare | Industry Medical Devices | Full time employees 80 | Website https://golifeward.com |
Full time employees 80 | Website https://golifeward.com | ||
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.